Solicitor's certificate of service on behalf of Livia Aumand confirming service of Doc. #31 upon Respondent/Patentee - Novartis AG by personal service on 27-JAN-2014 confirming service Doc. #31 upon Respondent - Teva Canada Ltd. by telecopier on 27-JAN-2014 confirming service Doc. #31 upon Respondent - Minister of Health by telecopier on 27-JAN-2014 filed on 27-JAN-2014

Discontinuance on behalf of Applicant filed on 27-JAN-2014

Acknowledgment of Receipt received from all parties with respect to Order Doc. 30 Transmitted by e-mail on 18-DEC-2013: receipt acknowledged by the Applicant and the Respondent Teva Canada Limited on 18-DEC-2013; by the Respondent Minister of Health on 19-DEC-2013. placed on file on 18-DEC-2013

Order dated 18-DEC-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 17-DEC-2013 Result: granted in part "1. These Applications are hereby consolidated for hearing. 2. All issues in these Applications are to be heard and determined together, and on the basis of common evidence. 3. All further documents are to bear both styles of cause and are to be filed in Court file T-289-12 only. 4. A copy of this Order is to be placed on Court file T-1969-13." Filed on 18-DEC-2013 copies sent to parties entered in J. & O. Book, volume 1214 page(s) 338 - 339 Interlocutory Decision

Communication to the Court from the Registry dated 18-DEC-2013 re: Letter dated 17-DEC-2013

Letter from Applicant on behalf of all parties dated 17-DEC-2013 requesting that this application be joined with T-1969-13, and that the matters be heard and determined at the same time, on the basis of the same evidence and argument, as already filed in T-289-12. Draft order attached. received on 17-DEC-2013

Acknowledgment of Receipt received from all parties via successful fax transmission with respect to Order Doc 29 placed on file on 12-NOV-2013

Order dated 12-NOV-2013 rendered by The Honourable Mr. Justice Hughes Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 08-NOV-2013 re: Adjournment of hearing, scheduled for Nov 18-19 in Toronto Result: 1. The hearing of this matter presently scheduled for November 18 and 19, 2013 is adjourned sine die; 2. The Parties shall report to Prothonotary Tabib at the earlier of six months from the date of this Order or the disposition of A-318-13, to determine if a new hearing date is required; and 3. No Order as to costs. Filed on 12-NOV-2013 copies sent to all parties (via telephone and fax) entered in J. & O. Book, volume 1210 page(s) 18 - 19 Interlocutory Decision

Letter from Applicant dated 08-NOV-2013 "...The parties have been able to reach an agreement, so that both of these parties respectfully request an adjournment of the hearing of the within proceeding, currently scheduled for November 18-19 in Toronto..." with proof of service upon Respondent on 08-NOV-2013 received on 12-NOV-2013

Acknowledgment of Receipt received from MOH (via email) & Applicant and Respondent (via email read receipt) with respect to Oral Direction (Hughes J.) dated 5-NOV-2013 placed on file on 07-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Hughes dated 05-NOV-2013 directing that "I have Counsel for the Applicants' letter of November 4, 2013 and Counsel for the Respondents' reply letter of November 5, 2013. Given that there is no consent the trial scheduled for November 18-19, 2013 will go ahead as scheduled." placed on file on 05-NOV-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 05-NOV-2013 re: Respondent's letter dated 5-NOV-2013

Letter from Applicant dated 05-NOV-2013 "Teva does not agree tha an adjournment is appropriate for several reasons ..." (scanned to the Court) with proof of service upon Respondent on 05-NOV-2013 received on 05-NOV-2013

Covering letter from Applicant dated 04-NOV-2013 concerning ID:67 (Vol.14 A's Record) and doc.28 placed on file on 04-NOV-2013

Solicitor's certificate of service on behalf of Livia Aumand confirming service of missing pages of Volume 14 of the Applicant's Record upon Respondent by hand and Respondent Patentee by by email on 01-NOV-2013 filed on 04-NOV-2013

Vol.14 of Applicant's Record (resubmitted due to missing pages) 3 copies received on 04-NOV-2013

Letter from Applicant dated 04-NOV-2013 requesting an ajourdnment of the Judicial Review scheduled for November 18, 2013 and a Trial Management Conference at the earliest date that is most convenient for this Court. *scanned to the Court* received on 04-NOV-2013

Solicitor's certificate of service on behalf of A. CHANDIMAL NICHOLAS confirming service of DOC 26 AND BOOK OF AUTH(1-4 VOL.) upon Applicant RESPONDENT(MINISTER OF HEALTH) by COURIER on 18-OCT-2013 filed on 18-OCT-2013

Book of Authorities consisting of 4 volume(s) on behalf of RESPONDENT(TEVA) received on 18-OCT-2013

Memorandum of fact and law on behalf of Respondent(TEVA CANADA LIMITED) filed on 18-OCT-2013 1 judges' copies retained by the local office

Memorandum to file from Toronto dated 20-AUG-2013 Support-IT was informed of letter from Applicant's request for breakout rooms with internet access. placed on file.

Solicitor's certificate of service on behalf of Livia Aumand confirming service of Applicant's Application Record and Book of Authorities upon the Respondent Novartis AG by personal service on 03-SEP-2013 confirming service Applicant's Application Record and Book of Authorities upon counsel for the other Respondents by by hand on 03-SEP-2013 filed on 03-SEP-2013

Book of Authorities consisting of 4 volume(s) on behalf of Applicant received on 03-SEP-2013

Application Record Number of copies received/prepared: 3 on behalf of Applicant (Vol 1 to 17) filed on 03-SEP-2013 Document placed in Annexes B C D E F G

Letter from Applicant dated 20-AUG-2013 "...we write regarding breakout accommodations for the hearing of this matte on November 18-19, 2013. Novartis requests one break-out room for the duration of the hearing, with internet access, if possible." received on 20-AUG-2013

Acknowledgment of Receipt received from all parties with respect to Direction of the Court (Hughes, J.) issued 25-JUL-2013. placed on file on 26-JUL-2013

Oral directions received from the Court: The Honourable Mr. Justice Hughes dated 25-JUL-2013 directing that "The parties have leave to file memoranda of fact and law not exceeding 40 pages in length." placed on file on 25-JUL-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 23-JUL-2013 re: Letters dated 19-JUL-2013

Letter from Applicant dated 19-JUL-2013 advising pursuant to para. 7 of the Order of the Court dated September 12, 2012 that the final transcript has been received. received on 19-JUL-2013

Consent on behalf of all parties to the draft Order attached as Schedule "A" filed on 19-JUL-2013

Letter from Applicant dated 19-JUL-2013 on behalf of both parties requesting that the Court waive compliance with Rule 70 (4) of the Federal Courts Rules to allow the parties to each file a Memoranda of Fact and Law exclusive of appendices which exceed 30 pages in length but are no more then 40 pages for the reasons set out in the letter. A Draft Order is attached to the letter. The Applicant's request that the formality of filing a Rule 369 motion be dispensed with. received on 19-JUL-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 22 Transmitted by e-mail on 23-MAY-2013: receipt acknowledged by the Applicant on 23-MAY-2013; by the Respondents Teva Canada Limited and the Minister of Health on 27-MAY-2013. placed on file on 27-MAY-2013

Order dated 23-MAY-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 14-MAY-2013 Result: granted "1. The time for completing cross-examinations on affidavits is extended to 12-JUL-2013. 2. The remaining schedule set out in the Order of 12-SEP-2012 is unchanged." Filed on 23-MAY-2013 copies sent to parties entered in J. & O. Book, volume 1194 page(s) 28 - 29 Interlocutory Decision

Communication to the Court from the Registry dated 21-MAY-2013 re: letter dated 14-MAY-2013

Letter from Applicant dated 14-MAY-2013 on behalf of all parties, requesting that the deadline to complete cross-examinations be extended to 12-JUL-2013. Draft order attached. received on 14-MAY-2013

Acknowledgment of Receipt received from all parties (by fax) with respect to doc 21 placed on file on 09-APR-2013

Order (time and place) dated 09-APR-2013 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Toronto on 18-NOV-2013 to begin at 09:30 duration: 2d language: E Filed on 09-APR-2013 cc's sent to parties entered in J. & O. Book, volume 1189 page(s) 6 - 7 Transmittal letters placed on file

Communication to the Court from the Registry dated 03-APR-2013 re: Requisition for Hearing sent to JA for scheduling.

Solicitor's certificate of service on behalf of Livia Aumand confirming service of document 19 upon Respondent by telecopier on 28-MAR-2013 confirming service same upon Respondent Patentee by personal service on 28-MAR-2013 filed on 28-MAR-2013

Requisition for hearing - Application from Applicant filed on 28-MAR-2013 Tariff Application or appeal - $50.00

Solicitor's certificate of service on behalf of Livia Aumand confirming service of validity evidence of the applicant upon all parties by personal service and electronic service on consent on 14-JAN-2013 filed on 14-JAN-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 23-OCT-2012 directing that "Teva has not explained why the usual practice for requesting and setting a hearing date should not be followed and why a hearing date should be set by the Case Management Judge in the course of a case management conference. A requisition for hearing shall be served and filed no earlier than January 30, 2013 and not later than March 29, 2013." placed on file on 23-OCT-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 19-OCT-2012 re: Further submissions from the parties regarding the date for filing of the Requisition for Hearing

Letter from Respondent dated 18-OCT-2012 in response to the Respondent's Letter dated 18-OCT-2012 received on 18-OCT-2012

Letter from Respondent dated 17-OCT-2012 in response to the letter from counsel for the Applicant dated Oct. 10, 2012...Teva does not contest Novartis' submission that the requisition should not be filed until March 29, 2013, however, Teva respectfully requests that a case management conference be convened shortly after Novartis' evidence on invalidity is served on Jan. 14, 2013 so as to set a hearing date, as was done in T-1420-11. received on 18-OCT-2012

Letter from Applicant dated 18-OCT-2012 in response to Teva's letter dated October 17th, which was sent 1 week after the Court-directed deadline for submissions with respect to the filing of the requisition for hearing...Teva's request that the Court set the hearing date at a case management conference shortly after Jan. 14, 2013 does not address the concerns raised in Novartis' letter...It remains Novartis' position that the hearing should not be set down and no requisition for hearing should be filed until March 29, 2013. received on 18-OCT-2012

Communication to the Court from the Registry dated 18-OCT-2012 re: Applicant's submissions/letter re: date to file requisition for hearing

Solicitor's certificate of service on behalf of Chandimal Nicholas confirming service of Teva's evidence (on validity) upon all parties by email and courier on 12-OCT-2012 filed on 12-OCT-2012

Letter from Applicant dated 10-OCT-2012 further to the direction of the court dated September 12, 2012 requesting parties to file submissions as to the appropriate time for parties to serve and file their requisition for hearing. For the reasons that follow, Novartis' submission is that the Requisition should not be filed until March 29, 2013. Teva may bring a motion to dismiss the within application pursuant to s.6(5) of the PM(NOC) regs. sometime during the first quarter of 2013... received on 10-OCT-2012

Acknowledgment of Receipt received from all parties by email on Sept. 27th with respect to Doc.16 placed on file on 27-SEP-2012

Amended PROTECTIVE ORDER rendered on 27-SEP-2012 by Mireille Tabib, Prothonotary filed on 27-SEP-2012 Matter considered without personal appearance amending DOC.10 entered in J. & O. Book, volume 1169 page(s) 148 - 156 Interlocutory Decision certified copies sent to parties Transmittal letters placed on file.

Communication to the Court from the Registry dated 27-SEP-2012 re: Novartis' request for an Amended Protective Order (par.5), on consent of all parties

Letter from Applicant dated 06-SEP-2012 requesting the variance of paragraph 5 of the Protective Order issued on April 12, 2012. All parties request that this Amended Protective Order be issued. (Draft Order enclosed) received on 06-SEP-2012

Communication to the Court from the Registry dated 10-SEP-2012 re: Letter from Teva seeking amendments to the scheduling Order dated April 12, 2012. All parties consent to the requested amendments. (Sent to Court via email)

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 12-SEP-2012 directing that "The Court notes that the schedule does not yet provide for the filing of a Requisition for Hearing. The parties are to file submissions, by 10-OCT-2012, as to what should be the appropriate time for the parties to serve and file their Requisition for Hearing." placed on file on 12-SEP-2012 Confirmed in writing to the party(ies)

Order dated 12-SEP-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent Teva Canada Limited dated 04-SEP-2012 Result: granted "1. The Respondent Teva's evidence on invalidity shall be served no later than 12-OCT-2012. 2. The Respondent Teva's evidence on infringement shall be served no later than 12-OCT-2012. 3. The Applicant's evidence on invalidity shall be served and filed (sic) no later than 14-JAN-2013. 4. Any Motion for leave to serve reply evidence shall be served and filed by 28-JAN-2013. 5. Cross-examinations shall be completed no later than 17-MAY-2013. 6. The Applicant's Application Record shall be served and filed within 45 days of the receipt of the last cross-examination transcript (provided that the parties agree that the transcript be ordered immediately after the last cross-examination). 7. The parties shall advise the Court promptly of the date on which the last cross-examination transcript is received. 8. The Respondent Teva's Application Record shall be served and filed no later than 45 days following service of the Applicant's Application Record." Filed on 12-SEP-2012 copies sent to parties entered in J. & O. Book, volume 1168 page(s) 140 - 142 Interlocutory Decision

Letter from Defendant dated 04-SEP-2012 On consent of the parties, we wish to vary the April 12, 2012 scheduling Order of Madam Prothonotary Tabib.. (Draft order attached) received on 05-SEP-2012

Acknowledgment of Receipt received from all parties by email July 17, 2012 with respect to Doc.14 placed on file on 17-JUL-2012

Order dated 17-JUL-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 03-JUL-2012 Result: 1. Service of the Applicant's factual evidence on invalidity is extended to no later than July 13, 2012. 2. The remaining schedule set out in the Order of April 12, 2012 remains unchanged. Filed on 17-JUL-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1163 page(s) 175 - 176 Interlocutory Decision

Solicitor's certificate of service on behalf of Livia Aumand confirming service of the factual and non infringement evidence of the Applicant upon all parties by personal service on 13-JUL-2012 filed on 13-JUL-2012

Communication to the Court from the Registry dated 13-JUL-2012 re: Applicant's letter dated July 3, 2012 requesting a variance of the scheduling order dated April 12, 2012 (On consent)

Letter from Applicant dated 03-JUL-2012 requesting a variance to paragraph 3 of the Scheduling Order dated April 12, 2012 to extend the time for service of the Applicant's factual evidence on validity from July 3 to July 13. This extension will not affect the remainder of the schedule...The parties request that the enclosed draft Order be issued... received on 03-JUL-2012

Acknowledgment of Receipt received from all parties by e-mail with respect to Order Doc. 12 placed on file on 30-MAY-2012

Order dated 25-MAY-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 17-MAY-2012 Result: granted - Verification Order Filed on 25-MAY-2012 copies sent to parties entered in J. & O. Book, volume 1158 page(s) 388 - 390 Interlocutory Decision

Communication to the Court from the Registry dated 24-MAY-2012 re: Letter dated 17-MAY-2012

Letter from Applicant dated 17-MAY-2012 re: "The parties have come to an agreement on a form of Order relating to the disclosure of documents from Teva's Abbreviated New Drug Submission and the verification of those documents by the Minister of Health under section 6(7) of the Patented Medicines (Notice of Compliance) Regulations. Therefore, the Applicant will not be bringing a Motion pursuant to section 6(7) of the Patented Medicines (Notice of Compliance) Regulations as contemplated in this Court's Order dated 12-APR-2012. The parties request that the enclosed Order be issued. The parties are available for a case management conference call to discuss the draft order at the Court's request." received on 18-MAY-2012

Acknowledgment of Receipt received from all parties by email with respect to doc.11 placed on file on 20-APR-2012

Order dated 12-APR-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 03-APR-2012 Result: granted "1. Teva Canada Limited ("Teva") shall deliver its response to the request for disclosure related to documents from Teva's Abbreviated New Drug Submission sent by the Applicant on 27-MAR-2012 by 10-APR-2012. 2. In the event that it is necessary for the Applicant to bring a Motion pursuant to section 6(7) of the Patented Medicines (Notice of Compliance) Regulations, it shall be served and filed by 8-MAY-2012. 3. The Applicant's factual evidence on invalidity shall be served no later than 3-JUL-2012. 4. The Applicant's evidence on non-infringement shall be served by the later of (i) 13-JUL-2012; or (ii) within 90 days of the provision by Teva of any additional relevant disclosure provided in response to the request for production sent on 27-MAR-2012 or in accordance with a Motion filed as per paragraph 2. 5. The Respondent Teva's evidence on invalidity shall be served no later than 4-SEP-2012. 6. The Respondent Teva's evidence on infringement shall be served no later than 60 days following the receipt of the Applicant's evidence on non-infringement. 7. The Applicant's evidence on invalidity shall be served no later than 5-DEC-2012. 8. Any Motion for leave to serve reply evidence shall be served and filed by 21-DEC-2012. 9. Cross-examinations shall be completed no later than 29-MAR-2013. 10. The Applicant's Record shall be served and filed within 45 days of the receipt of the last cross-examination transcript (provided that the parties agree that the transcript be ordered immediately after the last cross-examination). 11. The parties shall advise the Court promptly of the date on which the last cross-examination transcript is received. 12. The Respondent Teva's Record shall be served and filed no later than 45 days following service of the Applicant's Record." Filed on 13-APR-2012 copies sent to parties entered in J. & O. Book, volume 1154 page(s) 141 - 143 Interlocutory Decision

PROTECTIVE ORDER dated 12-APR-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 03-APR-2012 Result: granted Filed on 13-APR-2012 copies sent to parties entered in J. & O. Book, volume 1154 page(s) 132 - 140 Interlocutory Decision

Communication to the Court from the Registry dated 10-APR-2012 re: Applicant's letter dated April 3, 2012 enclosing a draft scheduling order and a draft protective order which are both on consent of all parties.

Letter from Applicant dated 03-APR-2012 enclosing a draft scheduling order on consent of all parties. Parties have also agreed on the form of the attached Protective Order and request that it be issued. received on 03-APR-2012

Letter from Applicant dated 07-MAR-2012 advising that the parties are currently negotiating schedules in T-288-12 and T-289-12, and hope to provide the Court with a proposal regarding the schedules shortly. received on 08-MAR-2012

Proof of Service of Fax received from All parties with respect to Doc. #9 (Order from CJC dated February 17, 2012). placed on file on 17-FEB-2012

Order dated 17-FEB-2012 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Order dated 17-FEB-2012 Result: Pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 17-FEB-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1149 page(s) 303 - 303 Interlocutory Decision

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Doc#7 upon Applicant by personal service on 16-FEB-2012 confirming service Doc#7 upon Respondent, Teva Canada Limited by telecopier on 16-FEB-2012 confirming service Doc#7 upon Respondent, Minister of Health by telecopier on 16-FEB-2012 filed on 16-FEB-2012

Notice of appearance on behalf of Respondent/Patentee, Novartis AG filed on 16-FEB-2012

Notice of appearance on behalf of respondent,Teva Canada Limited with proof of service upon applicant,respondent,Minister of Health,respondent,Novartis AG on 14-FEB-2012 filed on 14-FEB-2012

Affidavit of service of Erin McIntomny sworn on 13-FEB-2012 on behalf of Applicant confirming service of Notice of Application upon Respondent Respondent Patentee by personal service on 06-FEB-2012 confirming service Notice of Application upon Respondent Teva Canada Limited by personal service on 07-FEB-2012 filed on 13-FEB-2012

Affidavit of service of JAMES ADENEY sworn on 09-FEB-2012 on behalf of Respondent confirming service of DOC 3 upon all parties by telecopier on 09-FEB-2012 filed on 09-FEB-2012

Notice of appearance on behalf of Respondent filed on 09-FEB-2012

Service copy of Doc. No. 1 with proof of service upon Deputy Attorney General of Canada on 07-FEB-2012 filed on 07-FEB-2012

Notice of application and 2 copies with regard to section 6 of the Patented Medicines (Notice of Compliance) Regulations filed on 06-FEB-2012 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes